{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-071195","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2026-06-08T12:31:21+00:00","discovered_at":"2026-06-08T12:35:00.347709+00:00","generated_at":"2026-06-08T12:36:33.546452+00:00","sec_items":["1.01","3.02","5.01","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Standard BioTools to merge with Treeline Biosciences in all-stock deal; LAB stockholders to own ~16%","bullets":["All-stock merger; Treeline valued at $2.5B, Standard BioTools at ~$460M; combined co. to be named Treeline Biosciences Holdings.","Former LAB stockholders to hold ~16% of combined co., Treeline stockholders ~84%; closing expected H2 2026.","Legacy mass cytometry/microfluidics business to be sold or wound down; CVRs issued to LAB stockholders for proceeds.","Treeline CEO Josh Bilenker to lead combined co.; board to have 12 members, 10 from Treeline, 2 from LAB.","Voting agreements covering ~39% of LAB shares; termination fee of $16.1M payable by LAB in certain circumstances."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-071195","json":"https://secwatch.observer/filing/0001104659-26-071195.json","markdown":"https://secwatch.observer/filing/0001104659-26-071195.md","text":"https://secwatch.observer/filing/0001104659-26-071195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000110465926071195/0001104659-26-071195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000110465926071195/tm2617100d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T12:36:33.546452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"93e3b13cd1906b384e5af0119ced8272438a7527","claim":"STANDARD BIOTOOLS INC. entered into Agreement and Plan of Merger and Reorganization with Treeline Biosciences, Inc. (effective 2026-06-06).","evidence_excerpt":"Standard BioTools Inc., a Delaware corporation (“Standard BioTools”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Treeline Biosciences, Inc., a Delaware corporation (“Treeline”), and Siri Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Standard BioTools (“Merger Sub”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465926071195/0001104659-26-071195-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Treeline Biosciences, Inc."},{"label":"Effective","value":"2026-06-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}